Tuula Anneli Kallunki

Tuula Anneli Kallunki

Associate Professor


Publication year:
All
1 - 10 out of 12Page size: 10
  1. 2023
  2. Published

    Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis

    Skorda, A., Lauridsen, A. R., Wu, C., Huang, J., Mrácková, Monika, Winther, N. I., Jank, V., Sztupinszki, Z., Strauss, R., Bilgin, M., Maeda, K., Liu, B., Luo, Y., Jaattela, Marja & Kallunki, Tuula Anneli, 2023, In: Oncogene. 42, p. 2495–2506

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma

    Lahtinen, A., Lavikka, K., Virtanen, A., Li, Y., Jamalzadeh, S., Skorda, A., Lauridsen, A. R., Zhang, K., Marchi, G., Isoviita, V. M., Ariotta, V., Lehtonen, O., Muranen, T. A., Huhtinen, K., Carpén, O., Hietanen, S., Senkowski, W., Kallunki, T., Häkkinen, A., Hynninen, J. & 2 others, Oikkonen, J. & Hautaniemi, S., 2023, In: Cancer Cell. 41, 6, p. 1103-1117.e12

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysis

    Skorda, A., Lauridsen, A. R., Huhtinen, K., Lahtinen, A., Senkowski, Wojciech, Oikkonen, J., Hynninen, J., Hautaniemi, S. & Kallunki, Tuula Anneli, 2023, In: STAR Protocols. 4, 4, 17 p., 102683.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2022
  6. Published

    Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer

    Lima, T. S., De Oliveira Souza, Luciano, Iglesias Gato, Diego, Elversang, J., Jørgensen, Flemming Steen, Kallunki, Tuula Anneli, Røder, Andreas, Brasso, K. & Moreira, José, 2022, In: Frontiers in Pharmacology. 13, 13 p., 869461.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises

    Skorda, A., Bay, M. L., Hautaniemi, S., Lahtinen, A. & Kallunki, Tuula Anneli, 2022, In: Cancers. 14, 24, 33 p., 6257.

    Research output: Contribution to journal › Review › Research › peer-review

  8. 2021
  9. Published

    Identification of lysosome‐targeting drugs with anti‐inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers

    Hansen, M. B., Postol, M., Tvingsholm, S., Nielsen, I. Ø., Dietrich, T. N., Puustinen, P., Maeda, K., Dinant, C., Strauss, R., Egan, D., Jaattela, Marja & Kallunki, Tuula Anneli, 2021, In: Cellular Oncology. 44, p. 805–820

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. 2020
  11. Published

    Seeking and Exploring Efficient Ways to Target Cancer

    Kallunki, Tuula Anneli, 2020, In: Cells. 9, 9, 5 p., 2117.

    Research output: Contribution to journal › Editorial › Research › peer-review

  12. Published

    Zinc Finger Transcription Factor MZF1-A Specific Regulator of Cancer Invasion

    Brix, D. M., Clemmensen, K. K. B. & Kallunki, Tuula Anneli, 2020, In: Cells. 9, 18 p., 223.

    Research output: Contribution to journal › Review › Research › peer-review

  13. 2019
  14. Published

    How to Choose the Right Inducible Gene Expression System for Mammalian Studies?

    Kallunki, Tuula Anneli, Barisic, Marin, Jaattela, Marja & Liu, B., 2019, In: Cells. 8, 8, 16 p., 796.

    Research output: Contribution to journal › Review › Research › peer-review

  15. Published

    Molecular and Transcriptional Signatures for ErbB2-Induced Invasion

    Tvingsholm, S. A., Brix, D. M. & Kallunki, Tuula Anneli, 2019, In: Current Pharmacology Reports. 5, 1, p. 43-55 13 p.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 Next

ID: 195069018